Skip to main content
. 2020 Nov 25;23(1):80–98. doi: 10.1016/j.neo.2020.11.004

Table 1.

IC50 values after cisplatin, bortezomib and combined treatment of cell lines in vitro: 95% confidence intervals (CI) of IC50 values after 50 h of treatment. For combined treatment with a fix ratio of bortezomib to cisplatin of 1:10, the respective IC50 values of the bortezomib content is shown.

Cell Line 95% CI (IC50 Cisplatin) 95 % CI (IC50 Bortezomib) 95% CI (IC50 Combination, Given c[Bor])
BON 4.960 to 11.54 µM 0.01963 to 0.05009 µM 0.01148 to 0.01921 µM
LCC-18 9.056 to 31.38 µM 0.03125 to 0.1359 µM 0.05334 to 0.07376 µM
KRJ-I 2.386 to 6.931 µM 0.003470 to 0.008452 µM 0.001668 to 0.006319 µM